Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Current Leases (2023 - 2025)

Historic Current Leases for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $716000.0.

  • Upstream Bio's Current Leases rose 560.47% to $716000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $716000.0, marking a year-over-year increase of 560.47%. This contributed to the annual value of $704000.0 for FY2024, which is 146444.44% up from last year.
  • Upstream Bio's Current Leases amounted to $716000.0 in Q3 2025, which was up 560.47% from $712000.0 recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Current Leases peaked at $716000.0 during Q3 2025, and registered a low of $45000.0 during Q4 2023.
  • For the 3-year period, Upstream Bio's Current Leases averaged around $593833.3, with its median value being $706000.0 (2024).
  • As far as peak fluctuations go, Upstream Bio's Current Leases skyrocketed by 146444.44% in 2024, and later surged by 560.47% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Current Leases stood at $45000.0 in 2023, then surged by 1464.44% to $704000.0 in 2024, then increased by 1.7% to $716000.0 in 2025.
  • Its Current Leases stands at $716000.0 for Q3 2025, versus $712000.0 for Q2 2025 and $708000.0 for Q1 2025.